Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) – Equities research analysts at B. Riley reduced their Q3 2025 earnings estimates for Aspen Aerogels in a research note issued to investors on Wednesday, February 19th. B. Riley analyst R. Pfingst now expects that the construction company will post earnings of $0.13 per share for the quarter, down from their prior forecast of $0.16. B. Riley currently has a “Buy” rating and a $22.00 target price on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.22 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2025 earnings at $0.15 EPS, FY2026 earnings at $0.75 EPS and FY2027 earnings at $1.30 EPS.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%.
Read Our Latest Research Report on ASPN
Aspen Aerogels Stock Down 2.0 %
ASPN stock opened at $8.14 on Thursday. The company has a market cap of $667.48 million, a P/E ratio of 50.85 and a beta of 2.14. Aspen Aerogels has a 52 week low of $8.02 and a 52 week high of $33.15. The company’s 50-day moving average price is $11.85 and its 200 day moving average price is $18.22. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.
Institutional Trading of Aspen Aerogels
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Allspring Global Investments Holdings LLC grew its position in Aspen Aerogels by 415.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 238,884 shares of the construction company’s stock valued at $6,615,000 after purchasing an additional 192,520 shares in the last quarter. Dakota Wealth Management purchased a new position in Aspen Aerogels during the third quarter valued at approximately $986,000. Rice Hall James & Associates LLC grew its position in Aspen Aerogels by 19.9% during the third quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock valued at $14,817,000 after purchasing an additional 88,711 shares in the last quarter. Pursue Wealth Partners LLC purchased a new position in Aspen Aerogels during the third quarter valued at approximately $222,000. Finally, Bridgewater Advisors Inc. grew its position in Aspen Aerogels by 37.8% during the third quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company’s stock valued at $2,142,000 after purchasing an additional 21,218 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories
- Five stocks we like better than Aspen Aerogels
- What is a Bond Market Holiday? How to Invest and Trade
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How Can Investors Benefit From After-Hours Trading
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Investing in Commodities: What Are They? How to Invest in Them
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.